UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome

European heart journal, 2015-12, Vol.36 (45), p.3202-3210

2015

Volltextzugriff (PDF)

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial

JAMA : the journal of the American Medical Association, 2014-11, Vol.312 (19), p.1981

2014

Volltextzugriff (PDF)

Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

Journal of the American College of Cardiology, 2020-11, Vol.76 (21), p.2436-2446

2020

Volltextzugriff (PDF)

Gender balance at the heart of science

Cardiovascular research, 2020-08, Vol.116 (10), p.e115-e117

2020

Volltextzugriff (PDF)

Increased bleeding risk during percutaneous coronary interventions by arterial hypertension

Catheterization and cardiovascular interventions, 2016-08, Vol.88 (2), p.184-190

2016

Volltextzugriff (PDF)

Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial

Journal of Atherosclerosis and Thrombosis, 2022/05/01, Vol.29(5), pp.747-761

2022

Volltextzugriff (PDF)

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

Journal of the American Heart Association, 2021-11, Vol.10 (22), p.e021418-e021418

2021

Volltextzugriff (PDF)

Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor

European heart journal, 2020-09, Vol.41 (33), p.3153-3155

2020

Volltextzugriff (PDF)

Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply

The New England journal of medicine, 2020-01, Vol.382 (5), p.487-487

2020

Volltextzugriff (PDF)

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial

Journal of the American College of Cardiology, 2015-04, Vol.65 (16), p.1619-1629

2015

Volltextzugriff (PDF)

Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction

European heart journal, 2017-06, Vol.38 (21), p.1664-1665

2017

Volltextzugriff (PDF)

Round‐knit or flat‐knit compression garments for maintenance therapy of lymphedema of the leg? – Review of the literature and technical data

Journal der Deutschen Dermatologischen Gesellschaft, 2019-08, Vol.17 (8), p.775-784

2019

Volltextzugriff (PDF)

Safety of a compression stocking for patients with chronic venous insufficiency (CVI) and peripheral artery disease (PAD)

Journal der Deutschen Dermatologischen Gesellschaft, 2020-03, Vol.18 (3), p.207-213

2020

Volltextzugriff (PDF)

Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial

Journal of the American College of Cardiology, 2020-11, Vol.76 (21), p.2569-2571

2020

Volltextzugriff (PDF)

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)

European heart journal, 2021-07, Vol.42 (27), p.2630-2642

2021

Volltextzugriff (PDF)

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial

Annals of internal medicine, 2020-09, Vol.173 (6), p.436

2020

Volltextzugriff (PDF)

Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention

Thrombosis and haemostasis, 2024-04, Vol.124 (4), p.297

2024

Volltextzugriff (PDF)

S1 guidelines: Lipedema

Journal der Deutschen Dermatologischen Gesellschaft, 2017-07, Vol.15 (7), p.758-767

2017

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial

JACC. Cardiovascular interventions, 2015-06, Vol.8 (7), p.877-884

2015

Volltextzugriff (PDF)

Thick legs - not always lipedema

Journal der Deutschen Dermatologischen Gesellschaft, 2013-03, Vol.11 (3), p.225-233

2013

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(71)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(58)
Female
(39)
Male
(33)
Cardiovascular System & Cardiology
(32)
Aged
(28)
Treatment Outcome
(28)
Middle Aged
(27)
Cardiac & Cardiovascular Systems
(22)
Dermatology
(18)
Percutaneous Coronary Intervention
(16)
Risk Factors
(13)
Adult
(12)
Time Factors
(12)
Aged, 80 And Over
(10)
Peripheral Vascular Disease
(10)
Ticagrelor
(10)
Acute Coronary Syndrome - Drug Therapy
(9)
Biological And Medical Sciences
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial

Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

Gender balance at the heart of science

Increased bleeding risk during percutaneous coronary interventions by arterial hypertension

Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial

Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial

Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial

Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction

Round‐knit or flat‐knit compression garments for maintenance therapy of lymphedema of the leg? – Review of the literature and technical data

Safety of a compression stocking for patients with chronic venous insufficiency (CVI) and peripheral artery disease (PAD)

Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial

Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention

S1 guidelines: Lipedema

Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial

Thick legs - not always lipedema

Aktive Filter

Suchergebnisse filtern